HBcAb Positivity as a Risk Factor for Missing HIV RNA Undetectability after the 3TC+DTG Switch
Hepatitis B Core antibody (HBcAb) positivity is the surrogate marker of hepatitis B occult infection. This condition is not a contraindication for switching to two-drug (2DR) antiretroviral therapy; however, the removal of tenofovir may contribute to poor control of HBV replication. A multicentre re...
Main Authors: | Vincenzo Malagnino, Tiziana Mulas, Elisabetta Teti, Monica Basso, Mario Giobbia, Nicholas Geremia, Giuliana Battagin, Yasmine Abi Aad, Jean-Paul Vincensini, Marco Iannetta, Saverio Giuseppe Parisi, Loredana Sarmati, Karine Lacombe |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/16/3/348 |
Similar Items
-
Role of HBcAb Positivity in Increase of HIV-RNA Detectability after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Months 48 Results of a Multicenter Italian Cohort
by: Vincenzo Malagnino, et al.
Published: (2023-01-01) -
Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study
by: Ya-Chih Tien, et al.
Published: (2018-11-01) -
HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort
by: Vincenzo Malagnino, et al.
Published: (2021-02-01) -
The effectiveness of hepatitis B vaccine in toddlers based on the five-year period national basic health research (Riskesdas 2007, 2013 and 2018) in Indonesia
by: Christina Safira Whinie Lestari, et al.
Published: (2023-05-01) -
Efficacy of combined HBsAg, anti-HBc and anti-HBs screening in minimizing transfusion transmission risk of hepatitis B infection in low resource setting
by: Shreyasi Athalye, et al.
Published: (2024-02-01)